Can a weekly shot curb your cravings? yale study investigates
NCT ID NCT04779697
Summary
This Yale University study tested whether a GLP-1 drug (semaglutide) could help people with obesity by reducing cravings for tasty foods, lowering hunger, and decreasing stress. For 12 weeks, 96 participants received either the drug or a placebo (dummy treatment) to see its effects. The main goal was to understand how this type of medication might help with weight control by changing a person's relationship with food.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Yale Stress Center: Yale University
New Haven, Connecticut, 06519, United States
Conditions
Explore the condition pages connected to this study.